USPTO serial 99679496
CYLLENE THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FRUM MILONE, MARCIE R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with CYLLENE THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, Deluca, & Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Pharmaceutical preparations containing viral vectors for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Medicinal preparations for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for use as treatments of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Chemical reagents for medical or veterinary use; Biological reagents for medical use; Biological reagents for veterinary use; Bacterial preparations for medical purposes; Bacteriological preparations for medical purposes; Biological preparations for the treatment of neurological pathologies, innate or acquired chronic diseases, inflammatory diseases; Reagents for medical use; Reagents for veterinary use | ACTIVE | — |
| 042 | Research laboratory analysis services in the field of biological, biomedical, and pharmaceutical therapeutics; Research and development services in the field of pharmaceutical preparations; Research and development services in the field of medical preparations; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Pharmaceutical research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Biological research; Scientific research; Medical research; Scientific laboratory services; Scientific research in the field of genetics; Providing medical and scientific research information in the fields of pharmaceuticals and genetics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CYLLENE THERAPEUTICS
- Other trademarks owned by CYLLENE THERAPEUTICS
- Other trademarks owned by EG427
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named CYLLENE THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 3, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 7, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 5, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 5, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 5, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 26, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 3, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 3, 2026 | NWAP | NEW APPLICATION ENTERED | — |